BioNTech SE - ADR vs TeraWulf Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while TeraWulf Inc trades at $17.7 (market cap $8.35B). The key difference: BioNTech SE - ADR is far larger — about 2.8× TeraWulf Inc's market cap, and TeraWulf Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | WULF | |
|---|---|---|
Market Cap | $23.31B | $8.35B |
Sector | Health | Technology |
52-Week High | $119.34 | $28.98 |
52-Week Low | $83.89 | $5.24 |
Enterprise Value | $6.60B | $10.97B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →